Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors

Clinical trial NCT04292769 · UNKNOWN

Trial details

NCT number: NCT04292769
Sponsor: Li Yu
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Neoplasm

Start date: 2020-01-21
Primary completion: 2023-01-20
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.